SCHEMBL9603913

SCHEMBL9603913

c1ccc(-c2cc(-c3ccccc3)c3sc4c(-c5ccc(-c6nc7ccccc7o6)cc5)cc(-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.50
RAB9A P51151 6/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ATM Q13315 1/20 0.50
HPGD P15428 7/20 0.47
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
MAPT P10636 5/20 0.47
TP53 P04637 3/20 0.47
GAA P10253 2/20 0.47
LMNA P02545 1/20 0.47
NFKB1 P19838 1/20 0.47
STAT1 P42224 1/20 0.47
GFER P55789 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
HSD17B10 Q99714 5/20 0.47
CASP3 P42574 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9603916 0.93 TP53 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL8514091 0.92 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603921 0.92 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603925 0.90 NPC1 (0.44) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603927 0.86 NPC1 (0.45) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603917 0.85 KDM4E (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603915 0.84 NPC1 (0.52) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603993 0.84 NPC1 (0.52) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603933 0.84 NPC1 (0.45) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603923 0.84 NPC1 (0.43) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 NPC1 4611/4885RAB9A 3002/4885MEN1 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.